We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAA icon
1976
PRA Group
PRAA
$695M
$20.8K ﹤0.01%
1,177
+388
+49% +$6.04K
APLS
1977
DELISTED
Apellis Pharmaceuticals
APLS
$20.7K ﹤0.01%
825
+656
+388% +$15.4K
DEA
1978
Easterly Government Properties
DEA
$1.18B
$20.7K ﹤0.01%
977
-2,782
-74% -$60.4K
XPEL icon
1979
XPEL
XPEL
$1.21B
$20.6K ﹤0.01%
413
INSP icon
1980
Inspire Medical Systems
INSP
$1.48B
$20.6K ﹤0.01%
223
+217
+3,617% +$20.8K
DRH icon
1981
Diamondrock Hospitality Co
DRH
$2.64B
$20.6K ﹤0.01%
2,295
CELC icon
1982
Celcuity
CELC
$4.02B
$20.5K ﹤0.01%
206
SM icon
1983
SM Energy
SM
$7.08B
$20.5K ﹤0.01%
1,095
-2,645
-71% -$53.6K
ZG icon
1984
Zillow
ZG
$7.66B
$20.5K ﹤0.01%
300
-171
-36% -$12K
AVDL
1985
DELISTED
Avadel Pharmaceuticals
AVDL
$20.5K ﹤0.01%
949
PCH
1986
DELISTED
PotlatchDeltic
PCH
$20.4K ﹤0.01%
513
-5
-1% -$202
ALHC icon
1987
Alignment Healthcare
ALHC
$3.82B
$20.2K ﹤0.01%
1,024
+29
+3% +$521
IOSP icon
1988
Innospec
IOSP
$2.14B
$20.2K ﹤0.01%
264
+208
+371% +$15.7K
DENN
1989
DELISTED
Denny's
DENN
$20.2K ﹤0.01%
+3,243
New +$18.4K
SMP icon
1990
Standard Motor Products
SMP
$900M
$20.2K ﹤0.01%
547
XRN
1991
Chiron Real Estate Inc
XRN
$543M
$20.1K ﹤0.01%
597
-337
-36% -$11K
XRAY icon
1992
Dentsply Sirona
XRAY
$2.67B
$20.1K ﹤0.01%
1,760
-24,109
-93% -$283K
NBIS
1993
Nebius Group N.V.
NBIS
$42.7B
$20K ﹤0.01%
239
+126
+112% +$13.1K
KALV
1994
DELISTED
KalVista Pharmaceuticals
KALV
$19.9K ﹤0.01%
1,232
+455
+59% +$6.03K
VSH icon
1995
Vishay Intertechnology
VSH
$5.05B
$19.9K ﹤0.01%
1,373
-152
-10% -$2.3K
CABO icon
1996
Cable One
CABO
$247M
$19.9K ﹤0.01%
176
-18
-9% -$2.46K
BCI icon
1997
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.91B
$19.8K ﹤0.01%
+1,015
New +$22.6K
PFS icon
1998
Provident Financial Services
PFS
$3.15B
$19.8K ﹤0.01%
1,001
AMWD
1999
DELISTED
American Woodmark
AMWD
$19.7K ﹤0.01%
366
-431
-54% -$25.2K
HSTM icon
2000
HealthStream
HSTM
$827M
$19.7K ﹤0.01%
855
+293
+52% +$7.37K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.